These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2078284)

  • 21. Indolealkylamine and phenalkylamine hallucinogens: a brief overview.
    Glennon RA; Rosecrans JA
    Neurosci Biobehav Rev; 1982; 6(4):489-97. PubMed ID: 6757811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.
    Cohen ML; Robertson DW; Bloomquist WE; Wilson HC
    J Pharmacol Exp Ther; 1992 Apr; 261(1):202-8. PubMed ID: 1560366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple serotonin receptors and their physiological significance.
    Peroutka SJ; Snyder SH
    Fed Proc; 1983 Feb; 42(2):213-7. PubMed ID: 6337063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Hydroxytryptamine (5-HT) and SK&F 103829 contract canine lower esophageal sphincter smooth muscle by stimulating 5-HT2 receptors.
    Barnette MS; Grous M; Manning CD; Price WJ; Nelson AH; Bondinell WE; Barone FC; Ormsbee HS
    Receptor; 1992; 2(3):155-67. PubMed ID: 1472950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantum chemical studies on drug actions. 3. Correlation of hallucinogenic and anti-serotonin activity of lysergic acid derivatives with quantum chemical data.
    Kumbar M; Sankar DV
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):65-100. PubMed ID: 4734018
    [No Abstract]   [Full Text] [Related]  

  • 28. Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).
    Brandt SD; Kavanagh PV; Twamley B; Westphal F; Elliott SP; Wallach J; Stratford A; Klein LM; McCorvy JD; Nichols DE; Halberstadt AL
    Drug Test Anal; 2018 Feb; 10(2):310-322. PubMed ID: 28585392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014).
    Yang Y; An S; Liu Y; Guo XX; Gao L; Wei JF; Xu TR
    Expert Opin Ther Pat; 2016; 26(1):89-106. PubMed ID: 26609882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Hallucinogens on Unconditioned Behavior.
    Halberstadt AL; Geyer MA
    Curr Top Behav Neurosci; 2018; 36():159-199. PubMed ID: 28224459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indolamine hallucinogens as MAO inhibitor agents--theoretical approach.
    Brandys Y; Yehuda S
    Int J Neurosci; 1983 Nov; 21(3-4):251-5. PubMed ID: 6671882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [On the inhibition of various rat paw edemas by serotonin antagonists].
    VOGEL G; MAREK ML
    Arzneimittelforschung; 1961 Nov; 11():1051-4. PubMed ID: 13926418
    [No Abstract]   [Full Text] [Related]  

  • 33. A mesenteric mass in a chronic LSD user.
    Berk SI; LeBlond RF; Hodges KB; Aibe H; Schlechte JA
    Am J Med; 1999 Aug; 107(2):188-9. PubMed ID: 10460058
    [No Abstract]   [Full Text] [Related]  

  • 34. Classical and non-classical psychedelic drugs induce common network changes in human cortex.
    Dai R; Larkin TE; Huang Z; Tarnal V; Picton P; Vlisides PE; Janke E; McKinney A; Hudetz AG; Harris RE; Mashour GA
    Neuroimage; 2023 Jun; 273():120097. PubMed ID: 37031827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function.
    Roth BL; Willins DL; Kristiansen K; Kroeze WK
    Pharmacol Ther; 1998 Sep; 79(3):231-57. PubMed ID: 9776378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of serotonin in the regulation of the immune response].
    Jahnová E
    Bratisl Lek Listy; 1994 Apr; 95(4):181-4. PubMed ID: 7812819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade by bufotenidine of the serotonin- and narcotic-analgesics-induced contraction of dog intestine in vivo.
    De Oliveira LF; Bretas AD
    Eur J Pharmacol; 1973 Mar; 21(3):369-71. PubMed ID: 4708072
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of antiserotonin on the experimental psychosis induced by dimethyltryptamine.
    SAI-HALASZ A
    Experientia; 1962 Mar; 18():137-8. PubMed ID: 14496041
    [No Abstract]   [Full Text] [Related]  

  • 39. Beware of blotting paper hallucinogens: severe toxicity with NBOMes.
    Isbister GK; Poklis A; Poklis JL; Grice J
    Med J Aust; 2015 Sep; 203(6):266-7e.1. PubMed ID: 26377297
    [No Abstract]   [Full Text] [Related]  

  • 40. Functional activity of 5-HT2 receptors in the modulation of the sleep/wakefulness states.
    Dugovic C
    J Sleep Res; 1992 Sep; 1(3):163-168. PubMed ID: 10607046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.